Welcome to the e-CCO Library!

P249: Validation of a Novel Integral Disease Index (NIDI) for evaluating the grade of activity in Mexican patients with ulcerative colitis: a prospective cohort study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. Yamamoto-Furusho*1, K. Bozada-Gutiérrez1, F. Bojalil-Romano1, R. Barreto-Zuñiga2, B. Martínez-Benitez3

Created: Friday, 22 February 2019, 9:41 AM
P249: What’s the role of anti-TNF α in correcting anemia in Crohn’s disease?
Year: 2021
Source: ECCO'21 Virtual
Authors: Hassine, A.(1);Hammami, A.(1);Jaziri, H.(1);Elleuch, N.(1);Ksiaa, M.(1);Ben Slama, A.(1);Jmaa, A.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P250 Root cause analysis to identify missed opportunities for the diagnosis of colorectal cancer in inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

C. Gordon1, D. Chee1, B. Hamilton1, N. Chanchlani1, N.M. Heerasing1, P. Hendy1, S. Lin1, E. Wesley1, I. Daniels2, J.R. Goodhand1, N.A. Kennedy1, T. Ahmad1

Created: Thursday, 30 January 2020, 10:12 AM
P250: Clinical validation of a point of care test for fecal calprotectin in distinguishing irritable bowel syndrome from Inflammatory Bowel Disease
Year: 2022
Source: ECCO'22
Authors: Bray, K.(1);Bahur, B.(2);Yadav, M.(3);Skinner, M.(3);Wong, M.(3);Chon, K.(3);Huang, R.(3);Day, V.(3);Mimms, L.(3);Hale, M.(3);
Created: Friday, 11 February 2022, 3:52 PM
P250: Does Ethnicity Influence Patient’s Preferences for Treatment Outcome? The Israeli Experience
Year: 2021
Source: ECCO'21 Virtual
Authors: Broide, E.(1);Richter, V.(1);Mari, A.(2); Khoury, T.(2); Shirin, H.(1);Naftali, T.(3);
Created: Wednesday, 2 June 2021, 4:12 PM
P250: DUBLIN (Degree of Ulcerative Colitis Burden of Luminal INflammation) score, a simple method to quantify inflammatory burden in ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Rowan C.R.*1, Twomey P.2, Cullen G.1,2, Sheridan J.1,2, Mulcahy H.1,2, Ryan E.2, Doherty G.A.1,2

Created: Wednesday, 20 February 2019, 10:36 AM
P250: Frequency of extraintestinal manifestation in the early signs and symptoms of inflammatory bowel disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. C. Silva1, B. C. da Silva*2, 3, J. Silva1, B. Brito1, I. Silva1, V. Nóbrega1, F. Fortes4, A. Pimentel4, N. Almeida4, V. Surlo4, J. Mota4, G. Santana1

Created: Friday, 22 February 2019, 9:49 AM
P250: Serious infection in patients with Crohn’s disease newly treated with anti-integrin and anti-tumour necrosis factor agents: A real-world study
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Afzali1*, X. Song2, N. Shi2, M. Skup3, W.-J. Lee3

Created: Thursday, 21 February 2019, 9:14 AM
P250: The impact of Primary Sclerosing Cholangitis (PSC) on fecal calprotectin assessment in individuals with Inflammatory Bowel Disease (IBD)
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Arar, A.(1);Scott, F.(2);Click, B.(2);Fennimore, B.(2);Ahmed, W.(2);Oonk, A.(2);Gerich, M.(2)*;
Created: Friday, 14 July 2023, 11:05 AM
P250: Use of complementary and alternative medicine is associated with chronic fatigue and lower health-related quality of life in patients with inflammatory bowel disease 20 years after diagnosis: results from the IBSEN study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

R. Opheim*1,2, J. Jahnsen2,3, G. Huppertz-Hauss4, T. Bernklev2,5, O. Høie6, M. Bjørn1,2

Created: Friday, 22 February 2019, 9:41 AM
P251 Small bowel capsule endoscopy is a valuable diagnostic tool in isolated terminal ileitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. FREITAS1,2,3, T. Cúrdia Gonçalves1,2,3, P. Boal Carvalho1,2,3, F. Dias de Castro1,2,3, B. Rosa1,2,3, M.J. Moreira1,2,3, J. Cotter1,2,3

Created: Thursday, 30 January 2020, 10:12 AM
P251: Antiphospholipid antibodies in Crohn's disease: Results of a prospective single-center study
Year: 2021
Source: ECCO'21 Virtual
Authors: Serghini, M.(1);Ben Youssef, H.(1);baccouche , H.(2);hafi, M.(1);labidy, A.(1);ben mustapha, N.(1);fekih, M.(1);boubaker, J.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P251: Comparison of 3 magnetic resonance enterography indices for detection of activity and severity in Crohn’s disease
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

I. Alfaro*1, I. Ordás1, S. Rodríguez2, J. Castro1, A. López1, T. Pérez3, A. Cofiño4, A. Ramírez-Morros1, M. Gallego1, R. Barastegui1, A. Giner1, M. Masamunt1, E. Ricart1, J. Rimola2, J. Panés1

Created: Friday, 22 February 2019, 9:49 AM
P251: Endoscopic and pathologic findings of the esophago-gastroduodenal involvement of Crohn’s disease in Korea: a prospective cohort study
Year: 2022
Source: ECCO'22
Authors: Kim, G.H.(1);Kim, J.(2);Park, S.H.(1);Ahn, J.Y.(1);Ye, B.D.(1);Jung, H.Y.(1);Yang, S.K.(1);
Created: Friday, 11 February 2022, 3:52 PM
P251: High anti-TNF drugs trough levels are not associated with the occurrence of adverse events in patients with inflammatory bowel diseases
Year: 2018
Source: ECCO '18 Vienna
Authors:

G. Bodini1*, M.G. Demarzo1, M. Saracco1, C. Coppo1, I. Baldissarro1, J. Anjali2, E. Savarino3, V. Savarino1, E. Giannini1

Created: Thursday, 21 February 2019, 9:14 AM
P251: Level of Interleukin-17 in Inflammatory Bowel Disease and Its relation to disease activity.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Menesy, A.(1);Hammad, M.(1);Aref, S.(2);Abozeid, F.(1)*;
Created: Friday, 14 July 2023, 11:05 AM
P251: RAID Dx: the first test based on faecal microbiota to differentiate irritable bowel syndrome from inflammatory bowel diseases
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. Amoedo*1,2, S. Ramió-Pujol1, A. Bahí3, C. Puig-Amiel3, L. Oliver1, L. Torrealba4, G. Ibáñez-Sanz5, A. Clos6, M. Mañosa6, F. Cañete6, I. Marín6, P. Torres6, P. Gilabert5, J. O. Miquel-Cusachs4, D. Busquets4, M. Serra-Pagès1, M. Sàbat7, J. Serra6, E. Domènech6, J. Guardiola5, F. Mearin8, L. J. Garcia-Gil1,2, X. Aldeguer1,3,4

Created: Friday, 22 February 2019, 9:41 AM
P251: The contribution of clinical and psychosocial factors to fatigue in 182 patients with inflammatory bowel disease: a cross-sectional study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Artom M., Czuber-Dochan W., Sturt J., Murrells T., Norton C.

Created: Wednesday, 20 February 2019, 10:36 AM
P252 The cardiovascular risk profile in patients with inflammatory bowel disease: A cross-sectional single-centre study (the CARE-IBD study)
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J.A.M. Sleutjes1, J.E. Roeters van Lennep2, P.J. Verploegh1, C.J. van der Woude1, A.C. de Vries1

Created: Thursday, 30 January 2020, 10:12 AM
P252: Assessment of ulcerative colitis using histological indexes
Year: 2018
Source: ECCO '18 Vienna
Authors:

F. Magro1,2,3, J. Lopes4, P. Borralho5, S. Lopes6, R. Coelho6, J. Cotter7, F. Dias de Castro7, H. T. Sousa8, P. Lago9, M. Salgado9, P. Andrade6, A.I. Vieira10, P. Figueiredo10, P. Caldeira11, A. Sousa11, M.A. Duarte12, F. Ávila12, J. Silva13, J. Moleiro13, S. Mendes14, S. Giestas14, P. Ministro15, P. Sousa15, R. Gonçalves16, B. Gonçalves16, A. Oliveira17, I. Rosa18, M. Rodrigues4, C. Chagas19, J. Torres20, C.C. Dias21,22, J. Afonso1,3*, K. Geboes23, F. Carneiro4,24

Created: Thursday, 21 February 2019, 9:14 AM